Mathematical model of a personalized neoantigen cancer vaccine and the human immune system.
Cancer vaccines are an important component of the cancer immunotherapy toolkit enhancing immune response to malignant cells by activating CD4+ and CD8+ T cells. Multiple successful clinical applications of cancer vaccines have shown good safety and efficacy. Despite the notable progress, significant...
Guardado en:
Autores principales: | Marisabel Rodriguez Messan, Osman N Yogurtcu, Joseph R McGill, Ujwani Nukala, Zuben E Sauna, Hong Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34612679abed4dbf841986552536e7d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4+ T-cells
por: Vijaya L. Simhadri, et al.
Publicado: (2021) -
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
por: Alexandre Harari, et al.
Publicado: (2021) -
Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
por: Samuel Rivero-Hinojosa, et al.
Publicado: (2021) -
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
por: Anna Morena D’Alise, et al.
Publicado: (2019) -
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
por: Daniel J. McGrail, et al.
Publicado: (2018)